We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Serum Test Detects Bacterial Infection in Autoimmune Diseases

By LabMedica International staff writers
Posted on 19 Jun 2012
Print article
The serum procalcitonin test (PCT) has been used to detect bacterial infection in patients with autoimmune diseases.

The clinical manifestations of disease flare and infection overlap and are identified by similar laboratory markers so there is an urgent need for a reliable biomarker that discriminates early infection from disease flare in febrile patients with autoimmune disease (AD).

Scientists from Chang Gung University (Tao Yuan, Taiwan) have reviewed studies carried out between January 1966 and October 2011 that had evaluated PCT as a diagnostic marker for bacterial infection in patients with AD, which included nine studies for PCT and five studies for C-reactive protein (CRP).

In healthy individuals, serum PCT is normally undetectable below 0.05 ng/mL, but the level increases rapidly after bacterial infection. In contrast to CRP, PCT does not rise with noninfectious inflammation or nonbacterial infections, making it a potentially useful marker to distinguish bacterial infection from disease flare in the setting of autoimmune disease.

The positive likelihood ratio for PCT was sufficiently high to be qualified as a rule-in diagnostic tool, while the negative likelihood ratio was not sufficiently low to be qualified as a reliable rule-out diagnostic tool. The area under the receiver-operating curve was higher for PCT than for CRP. Both markers had suboptimal negative likelihood ratios and so are not suitable tests for excluding bacterial infection in febrile patients with autoimmune diseases.

The authors conclude that different cut off levels are needed to optimize the discriminative capability of PCT for different autoimmune diseases. However, this requires a large study or studies of patients with the same autoimmune disease.

Until the results of such studies are available, they recommend using a standard PCT cut off value of 0.5 ng/mL, which has reasonable sensitivity of 76% and specificity of 88%.

Shy-Shin Chang, MD, lead author of the study said, "Analysis of the pooled data suggests that PCT is a more specific indicator of bacterial infection than CRP, but that CRP is a more sensitive indicator of bacterial infection than PCT." The study was published online on May 17, 2012, in the journal Arthritis and Rheumatism.

Related Links:
Chang Gung University


Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Centrifuge
Centrifuge 5430/ 5430 R
New
Anti-Secukinumab ELISA
LISA-TRACKER anti-Secukinumab

Print article

Channels

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.